|
|
||||||||
Department of Respiratory Diseases, Ghent University Hospital, Ghent, Belgium
The cellular and molecular mechanisms involved in the airway
hyperresponsiveness (AHR) of patients with allergic asthma remain
unclear. A role for Th2 inflammatory cells was suggested based on
murine asthma models. No direct evidence exists on the role of these
cells in human asthma. The development of a mouse-human chimera might
be useful, allowing the in vivo study of the components of the human
immune system relevant to asthma. We investigated the role of
allergen-reactive T lymphocytes in a human-mouse SCID model. SCID mice
were reconstituted intratracheally with human PBMC from healthy,
nonallergic, nonasthmatic donors and exposed to an aerosol of house
dust mite allergen after i.p. injection with Dermatophagoides
pteronyssinus I Ag and alum. The donor T lymphocytes had a Th1
cytokine phenotype. The reconstituted and allergen-challenged mice
developed AHR to carbachol. The mouse airways and lungs were
infiltrated with human T lymphocytes. No eosinophils or increases in
human IgE were observed. The intrapulmonary human T lymphocytes
demonstrated an increase in intracytoplasmic IL-4 and IL-5 and a
decrease in IFN-
after exposure to allergen adjuvant. Antagonizing
human IL-4/IL-13 or IL-5 resulted in a normalization of the airway
responsiveness, despite a sustained intracellular Th2 cytokine
production. These results provide evidence that the activated human
allergen-reactive Th2 cells producing IL-4 or IL-5 are pivotal in the
induction of AHR, whereas no critical role for eosinophils or IgE could
be demonstrated. They also demonstrate that human allergen-specific Th1
lymphocytes can be driven to a Th2 phenotype.
This article has been cited by other articles:
![]() |
D. D. Cataldo, K. G. Tournoy, K. Vermaelen, C. Munaut, J.-M. Foidart, R. Louis, A. Noel, and R. A. Pauwels Matrix Metalloproteinase-9 Deficiency Impairs Cellular Infiltration and Bronchial Hyperresponsiveness during Allergen-Induced Airway Inflammation Am. J. Pathol., August 1, 2002; 161(2): 491 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hertz, S. Mahalingam, I. Dalum, S. Klysner, J. Mattes, A. Neisig, S. Mouritsen, P. S. Foster, and A. Gautam Active Vaccination Against IL-5 Bypasses Immunological Tolerance and Ameliorates Experimental Asthma J. Immunol., October 1, 2001; 167(7): 3792 - 3799. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |